BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/06/2026

FDA Extends Effective Date of Drug Efficacy Study Implementation Notice

The FDA is extending the effective date of a notice related to estrogen-androgen fixed-combination drug products by 90 days, from June 26, 2026, to September 24, 2026, to allow sufficient time for consideration of issues raised by interested parties.

Source: Federal Register — Health and Human ServicesOpen original release →